We are live on ! Find out more
MME

Meag Munich Ergo Portfolio holdings

AUM $3.54B
1-Year Est. Return 20%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+20%
3 Year Est. Return
+82.79%
5 Year Est. Return
+144.54%
10 Year Est. Return
+335.02%
AUM
$2.45B
AUM Growth
+$194M
Cap. Flow
+$38.4M
Cap. Flow %
1.57%
Top 10 Hldgs %
19.65%
Holding
338
New
56
Increased
72
Reduced
61
Closed
74

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$35.8M
2
PG icon
Procter & Gamble
PG
+$27.7M
3
NEE icon
NextEra Energy
NEE
+$25.7M
4
SPGI icon
S&P Global
SPGI
+$23.2M
5
PFE icon
Pfizer
PFE
+$21.3M

Top Sells

Rank Stock Value
1
LH icon
Labcorp
LH
+$46.8M
2
UNH icon
UnitedHealth
UNH
+$24.9M
3
MMM icon
3M
MMM
+$23.4M
4
MU icon
Micron Technology
MU
+$20.3M
5
MDT icon
Medtronic
MDT
+$18M

Sector Composition

Rank Sector Weight
1 Technology 16.5%
2 Financials 16.05%
3 Healthcare 14.2%
4 Consumer Discretionary 9.53%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCI icon
126
Crown Castle
CCI
$32.4B
$6.22M 0.25%
+61,722
New +$6.31M
EW icon
127
Edwards Lifesciences
EW
$48.1B
$6.18M 0.25%
169,800
-20,253
-11% -$772K
STLA icon
128
Stellantis
STLA
$16.4B
$6.1M 0.25%
347,561
-61,308
-15% -$848K
BDX icon
129
Becton Dickinson
BDX
$44B
$5.84M 0.24%
30,830
+17,037
+124% +$3.3M
JNPR
130
DELISTED
Juniper Networks
JNPR
$5.79M 0.24%
208,357
+121,844
+141% +$3.41M
PRGO icon
131
Perrigo
PRGO
$1.43B
$5.66M 0.23%
+67,831
New +$5.28M
ALXN
132
DELISTED
Alexion Pharmaceuticals
ALXN
$5.62M 0.23%
40,469
+14,956
+59% +$2.03M
BNY
133
Bank of New York Mellon
BNY
$107B
$5.6M 0.23%
105,236
+55,256
+111% +$2.9M
AET
134
DELISTED
Aetna Inc
AET
$5.55M 0.23%
+35,174
New +$5.49M
RTN
135
DELISTED
Raytheon Company
RTN
$5.42M 0.22%
+29,387
New +$5.18M
COL
136
DELISTED
Rockwell Collins
COL
$5.42M 0.22%
+41,534
New +$5.05M
SLG icon
137
SL Green Realty
SLG
$3.84B
$5.41M 0.22%
55,266
UNP icon
138
Union Pacific
UNP
$177B
$5.37M 0.22%
46,195
-75,294
-62% -$8.08M
LYB icon
139
LyondellBasell Industries
LYB
$19B
$5.3M 0.22%
53,006
-91,977
-63% -$8.27M
OXY icon
140
Occidental Petroleum
OXY
$55.1B
$5.23M 0.21%
+80,271
New +$4.89M
DGX icon
141
Quest Diagnostics
DGX
$25.5B
$5.13M 0.21%
55,654
+22,665
+69% +$2.41M
GD icon
142
General Dynamics
GD
$105B
$5.13M 0.21%
24,946
+6,240
+33% +$1.25M
LH icon
143
Labcorp
LH
$24.7B
$5.08M 0.21%
39,378
-351,196
-90% -$46.8M
ABT icon
144
Abbott
ABT
$183B
$4.88M 0.2%
90,729
+57,899
+176% +$2.91M
TU icon
145
Telus
TU
$16.3B
$4.88M 0.2%
269,340
PCAR icon
146
PACCAR
PCAR
$69.3B
$4.81M 0.2%
+99,410
New +$4.48M
BIDU icon
147
Baidu
BIDU
$35.9B
$4.79M 0.2%
19,800
DHI icon
148
D.R. Horton
DHI
$41.2B
$4.71M 0.19%
+120,473
New +$4.39M
AAL icon
149
American Airlines Group
AAL
$9.68B
$4.67M 0.19%
97,958
-160,863
-62% -$7.78M
AMT icon
150
American Tower
AMT
$77.5B
$4.62M 0.19%
33,847

Similar funds

Meag Munich Ergo's Q3 2017 Portfolio in Review

As of Q3 2017, Meag Munich Ergo held 338 positions worth $2.45B, up 8.6% from $2.25B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Meag Munich Ergo's Q3 2017 filing shows 56 new, 72 increased, 61 reduced and 74 closed positions. Its largest new stake was NextEra Energy: 702,812 shares worth $25.9M. The largest sale was Labcorp, an estimated $46.8M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Meag Munich Ergo's largest Q3 2017 buy was NextEra Energy: 702,812 shares worth $25.9M.
  • Meag Munich Ergo added most to Meta Platforms (Facebook) in Q3 2017, an estimated $35.8M increase.
  • Meag Munich Ergo's biggest Q3 2017 reduction was Labcorp, cutting an estimated $46.8M.
  • Meag Munich Ergo fully exited Medtronic in Q3 2017, selling an estimated $18M.
  • Meag Munich Ergo's ten largest holdings make up 20% of its $2.45B portfolio in Q3 2017.
  • Meag Munich Ergo opened 56 new positions and closed 74 in Q3 2017.
  • Meag Munich Ergo's portfolio value rose 8.6% quarter-over-quarter to $2.45B.

Based on Meag Munich Ergo's 13F filing for Q3 2017, filed 6 Nov 2017.